|
|
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 25 • Issue 7 • February 17, 2022
|
|
|
Investigators identified "a quantifiable advantage of cannabis therapy for alleviating back pain" and "no serious adverse effects" in each of the studies reviewed.
|
|
|
|
|
|
"Overall, the cannabis industry has contributed $43.5 billion to Canada's GDP," authors determined.
|
|
|
New York: Lawmakers Advance Legislation to Expedite Adult-Use Cannabis ... Details
02/17/22 5:32pm UTC
Lawmakers, Cops Consider Adult-Use Cannabis Legalization in Pennsylvania Details
02/15/22 9:58pm UTC
Virginia: Senate Approves Adult-use Cannabis Retail Sales in Bipartisan Vote Details
02/15/22 10:00pm UTC
State Policy Weekly Update 2/11/2022 Details
02/11/22 5:57pm UTC
Retail Licensing Delays and Emerging Social Equity Concerns in NJ, NY, and CT Details
02/11/22 4:57pm UTC
|
|
|
|
|
|
Investigators identified an inverse association between cannabis use and incidences of myocardial infarction; they found no correlation between marijuana consumption and heart attack severity.
|
|
|
|
Additionally, 57 percent of respondents agreed that "the FDA should reclassify marijuana so that it is no longer a Schedule I drug" under federal law.
|
|
|
|
|
|
CBD/melatonin co-administration was associated with reduced feelings of anxiety, pain, depression, panic, and paranoia, as well as with "good general health perceptions."
|
|
|
|
Researchers concluded, "The most frequent phrases from the recovery subreddit referred to time without using opioids and the possibility of using cannabis as a 'treatment.'"
|
|
|
|
|
|
|
|
Sent via ActionNetwork.org.
To update your email address, change your name or address, or to stop receiving emails from NORML, please click here.
|
|
|
|